At its February 2026 meeting, EMA’s human medicines committee (CHMP) recommended 12 medicines for approval, covering vaccines, innovative treatments and biosimilars, and issued two negative opinions....
EMA’s human medicines committee (CHMP) published the outcomes of their meeting on Friday (30 January). EMA recommended six medicines for approval at its meeting and extended...
The latest annual surveillance report from the European Medicines Agency (EMA) shows a worrying increase in antimicrobial sales for animal use across the European Union. According...
NGOs and experts warned that a lack of funding and a clear regulatory pathway is stalling innovation in male birth control options. “Men are ready,” said...
The European Medicines Agency (EMA) has published a crucial scientific advice in the fight against Antimicrobial Resistance (AMR). It contains the experts' recommendations on antimicrobials and...
The European Medicines Agency (EMA) has started evaluating an application for a conditional marketing authorisation for the oral antiviral medicine Paxlovid (PF-07321332 and ritonavir). The applicant...
Greetings, colleagues, and here’s the latest European Alliance for Personalised Medicine (EAPM) update as we approach what we hope will be a normal ‘summer’. It’s all...
